NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Treatment-Resistant Depression Linked to Increased Mortality Risk
A new study has found that individuals with treatment-resistant depression (TRD) face a significantly higher risk of mortality compared to [...]
New Treatment for Non-Relapsing Secondary Progressive Multiple Sclerosis (SPMS)
A groundbreaking development in the treatment of multiple sclerosis (MS) has emerged, offering hope for those living with non-relapsing secondary [...]
Van Gogh’s Neurological and Psychiatric Conditions: What Could Have Affected the Famous Artist?
Vincent van Gogh’s life has long fascinated art lovers and medical professionals alike, especially when it comes to the neurological [...]
Understanding the Impact of Hurricanes on Neurological Health
Hurricanes and tropical storms are not just weather events—they can profoundly affect our health, particularly for individuals with neurological conditions. [...]
What You Need to Know About Alzheimer’s Disease: Early Symptoms and Diagnosis
Alzheimer’s disease is a progressive brain disorder that affects memory, thinking, and behavior. In a recent informative video, Dr. Richard [...]
How Is Alzheimer’s Disease Diagnosed? Understanding the Process
Alzheimer’s disease is the most common form of dementia, affecting millions of people worldwide. Early diagnosis is critical to managing [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social